7.15 USD
▲+0.03+1.56%
盘后 6.93 -1.56%
2026-08-03
市值
$788.64M
市盈率
—
EPS
-1.74
股息率
—
52 周区间
4.73 – 9.54
成交量
277.47K
Beta
0.40
目标价
18.80
52W 低 4.7352W 高 9.54
价格走势
公司简介
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder ...